{{Rsnum
|rsid=7747752
|Gene=CDKAL1
|Chromosome=6
|position=20725192
|Orientation=plus
|GMAF=0.3783
|Gene_s=CDKAL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 4.4 | 31.9 | 63.7
| HCB | 22.2 | 53.3 | 24.4
| JPT | 21.2 | 46.9 | 31.9
| YRI | 39.5 | 41.5 | 19.0
| ASW | 28.1 | 57.9 | 14.0
| CHB | 22.2 | 53.3 | 24.4
| CHD | 26.6 | 40.4 | 33.0
| GIH | 1.0 | 36.6 | 62.4
| LWK | 28.7 | 53.7 | 17.6
| MEX | 10.5 | 45.6 | 43.9
| MKK | 28.4 | 47.7 | 23.9
| TSI | 6.9 | 25.5 | 67.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22290723
|Trait=None
|Title=Association of glycosylated hemoglobin with the gene encoding CDKAL1 in the Korean Association Resource (KARE) study.
|RiskAllele=C
|Pval=1E-11
|OR=0.0460
|ORtxt=None
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}